Brind.

Securities Class Action Filed Against Ardelyx Executives Over Sales Projections

1 report, 1 independent Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A securities class action was filed against Ardelyx, Inc. on September 23, 2026, on behalf of shareholders who purchased securities between January 13, 2025, and August 6, 2026. The complaint names Michael Raab, Justin Renz, Susan Hohenleitner, and Eric Foster as individual defendants. The action alleges these officers controlled public statements that projected $1.75 billion in combined peak sales for XPHOZAH and IBSRELA.

From prnewswire.com

Why it matters

Some supportBrind's analysis of the reports

The lawsuit follows Ardelyx's August 6, 2026 announcement, which reduced full-year 2026 IBSRELA revenue guidance and withdrew long-term XPHOZAH revenue guidance. The allegations relate to the control of SEC reports and press releases, which directly affects investor trust and the company's financial disclosures.

From prnewswire.com

Who's involved

  • Michael RaabNamed as a defendant in a securities class action regarding company statements.
  • SECRegulatory body whose filings are the subject of the allegations.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped